AVILIVE obtains the novel crystalline form of picoxystrobin patent license from ALBAUGH for strategic collaboration.

Hangzhou,China, July 1st 2026-Zhejiang Avilive is pleased to announce the signing of patent licensing agreement with Albaugh Asia Pacific Limited to license Albaugh’s Patent in China on the Novel Crystalline form of Picoxystrobin, Under the agreement, Avilive enables technical-grade manufacturing and formulation development and producing, and offer the prodcuts to global markets. the patent is valid in China Until 2037-01-18.

浙江埃森化学有限公司获美爱保集团啶氧菌酯新型晶型专利授权以开展战略合作

2026 年 7 月 1 日，中国东阳 —— 浙江埃森化学有限公司欣然宣布，已与美爱保集团签署专利许可协议，取得美爱保集团在中国拥有的啶氧菌酯新型晶型专利授权。根据协议约定，浙江埃森化学有限公司可开展该产品原药生产与制剂研发生产工作，并面向全球市场供应相关产品。该专利在中国境内有效期至 2037 年 1 月 18 日。